BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12182170)

  • 1. Study outlines key factors in successful beta-blocker use.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):1-2, 5. PubMed ID: 12182170
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospitals boost performance with beta blocker data.
    Data Strateg Benchmarks; 2001 Oct; 5(10):149-51, 145. PubMed ID: 11682807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
    Brand DA; Newcomer LN; Freiburger A; Tian H
    J Am Coll Cardiol; 1995 Nov; 26(6):1432-6. PubMed ID: 7594066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are beta-blockers really underutilized in postinfarction patients?
    O'Rourke RA
    J Am Coll Cardiol; 1995 Nov; 26(6):1437-9. PubMed ID: 7594067
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why aren't we using beta blockers after acute MI?
    Weichel AS
    Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing beta-blocker use after myocardial infarction.
    Howard PA; Ellerbeck EF
    Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A slow trickledown. Data on efficacy of beta blockers belatedly spur use.
    Moore JD
    Mod Healthc; 1998 Sep; 28(37):70. PubMed ID: 10183097
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
    Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 11. Invited commentary.
    Gagne PJ
    J Vasc Surg; 2011 May; 53(5):1328. PubMed ID: 21575754
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
    Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
    Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta blocker use in acute myocardial infarction in West Virginia.
    Schade CP; Brehm JG; Stephens MK; Rezek G
    W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
    Ansari M; Shlipak MG; Heidenreich PA; Van Ostaeyen D; Pohl EC; Browner WS; Massie BM
    Circulation; 2003 Jun; 107(22):2799-804. PubMed ID: 12756157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 16. WVMI provides follow-up on beta blocker use.
    Schade CP
    W V Med J; 2002; 98(5):183. PubMed ID: 12440164
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.
    Dall L; Simmons T; Peterson S; Herndon B
    Manag Care Interface; 2000 May; 13(5):61-3, 69. PubMed ID: 11067397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative beta-blocker use: impact of national guidelines on clinical practice.
    Akhtar S; Assaad S; Amin M; Holt NF; Barash PG; Silverman DG
    J Clin Anesth; 2008 Mar; 20(2):122-8. PubMed ID: 18410867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.